west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "LIUFei" 2 results
  • Study of Algorithms Reconstructing Gene Regulatory Network with Resampling and Conditional Mutual Information

    Reconstruction of gene regulatory networks (GRNs) from large-scale expression data can mine the potential causality relationship among the genes and help understand the complex regulatory mechanisms. It is of utmost interest and has become a challenging computational problem for understanding the complex regulatory mechanisms in cellular systems. For the past decades, numerous theoretical and computational approaches have been introduced for inferring the GRNs. However, all existing methods of inferring GRNs from gene expression profiles have their strengths and weaknesses. In particular, many properties of GRNs, such as topology sparseness and non-linear dependence, are generally in regulation mechanism but are seldom taken into account simultaneously in one computational method. Some information theory algorithms do not recover the true positive edges that may have been deleted in an earlier computing process. These interaction relationships may reflect the actual relationship of genes. To overcome these disadvantages and to further enhance the precision and robustness of inferred GRNs, we presented an ensemble method, to infer GRNs from gene expression data by adopting two strategies of resampling and arithmetic mean fusion in this work. In this algorithm, the jackknife resampling procedure was first employed to form a series of sub-datasets of gene expression data, then the conditional mutual information was used to generate the corresponding sub-networks from the sub-datasets, and the final GRN was inferred by integrating these sub-networks with an arithmetic mean fusion strategy. Compared with those of the state-of-the-art algorithm on the benchmark synthetic GRNs datasets from the DREAM3 challenge and a real SOS DNA repair network, the results show that our method outperforms significantly LP, LASSO and ARANCE methods, and has a high and robust performance.

    Release date:2016-10-24 01:24 Export PDF Favorites Scan
  • Research on the Mechanism of Rosiglitazone in Improving Cognitive Impairment in Senile Diabetic Rats

    ObjectiveTo observe the effect of rosiglitazone on cognitive function, serum high sensitive C reactive protein (hs-CRP) and expression of nuclear factor-κB (NF-κB), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) in hippocampal tissues of senile diabetic rats. MethodsThirty aged Wistar rats (20-22 months) were randomly divided into normal control group (n=6), diabetic model group (n=12), and rosiglitazone treatment group (n=12). Streptozotocin-induced diabetic rat model was established. In the rosiglitazone treatment group, the rats were treated with rosiglitazone 4mg/kg/d for 8 weeks. The cognitive function of rats was evaluated with the Morris water maze test. Serum hs-CRP was detected by ELISA. The expression of NF-κB in hippocampal tissues was detected by western blot and IL-6 and TNF-α by Real-time PCR. ResultsThe Morris water maze test showed that escape latency was longer in the rosiglitazone treatment group and the diabetic model group than that in the control group (P<0. 05). Compared with the diabetic model group, the rosiglitazone treatment group showed a significant decrease in the average time of escape latencies (P<0.05), and an increased percentage of time spent in the central area and the more times navigating the original platform position (P<0.05). Serum hs-CRP and the expression of NF-κB, IL-6 and TNF-α in the rosiglitazone treatment group and the diabetic model group was significantly higher than those in the control group (P<0.01). Compared with the diabetic model group, serum hs-CRP and the expression of NF-κB, IL-6 and TNF-α in the rosiglitazone treatment group was decreased (P<0.05). ConclusionCognitive impairment in senile diabetic rats is associated with serum hs-CRP. The cognitive function can be improved with rosiglitazone treatment. The protective mechanisms may be related to the decrease of serum hs-CRP, inhibition of NF-κB signal and down-regulation of the expression of IL-6 and TNF-α in hippocampal tissues.

    Release date: Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content